FI934710L - 4-ARYL-3-(HETEROARYLUREIDO)QUINOLINE DERIVATIVES - Google Patents

4-ARYL-3-(HETEROARYLUREIDO)QUINOLINE DERIVATIVES Download PDF

Info

Publication number: FI934710L
Authority: FI; Finland
Prior art keywords: heteroarylureido; aryl; quinoline derivatives; quinoline; derivatives
Prior art date: 1991-04-26

Application number

FI934710A

Other languages

Finnish (fi)

Other versions

FI934710A0 (en

FI934710A7 (en

Inventor

Ernest S Hamanaka

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-26

Filing date

1992-03-16

Publication date

1993-10-25

1992-03-16 Application filed by Pfizer filed Critical Pfizer

1993-10-25 Publication of FI934710A0 publication Critical patent/FI934710A0/en

1993-10-25 Publication of FI934710A7 publication Critical patent/FI934710A7/en

1993-10-25 Publication of FI934710L publication Critical patent/FI934710L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)

FI934710A 1991-04-26 1992-03-16 4-ARYL-3-(HETEROARYLUREIDO)QUINOLINE DERIVATIVES FI934710L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US69232391A	1991-04-26	1991-04-26
PCT/US1992/001801 WO1992019614A1 (en)	1991-04-26	1992-03-16	4-aryl-3-(heteroarylureido)quinoline derivatives

Publications (3)

Publication Number	Publication Date
FI934710A0 FI934710A0 (en)	1993-10-25
FI934710A7 FI934710A7 (en)	1993-10-25
FI934710L true FI934710L (en)	1993-10-25

Family

ID=24780107

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI934710A FI934710L (en)	1991-04-26	1992-03-16	4-ARYL-3-(HETEROARYLUREIDO)QUINOLINE DERIVATIVES

Country Status (20)

Country	Link
EP (1)	EP0590094A1 (en)
JP (1)	JPH0776215B2 (en)
CN (1)	CN1066068A (en)
AU (1)	AU1879792A (en)
BR (1)	BR9205939A (en)
CA (1)	CA2108014A1 (en)
CZ (1)	CZ395592A3 (en)
DE (1)	DE9290049U1 (en)
FI (1)	FI934710L (en)
HU (1)	HUT65748A (en)
IE (1)	IE921330A1 (en)
IL (1)	IL101627A0 (en)
MX (1)	MX9201916A (en)
NO (1)	NO933837L (en)
NZ (1)	NZ242493A (en)
PT (1)	PT100426A (en)
TW (1)	TW197436B (en)
WO (1)	WO1992019614A1 (en)
YU (1)	YU44592A (en)
ZA (1)	ZA922976B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2668163B2 (en) *	1992-01-23	1997-10-27	ファイザーインク．	4-Aryl-3- (heteroarylureido) -1,2-dihydro-2-oxo-quinoline derivatives as cholesterolemia and anti-atherosclerosis drugs
US5565472A (en) *	1992-12-21	1996-10-15	Pfizer Inc.	4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) *	1993-08-13	1995-11-27	Nihon Nohyaku Co Ltd	N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) *	1995-05-19	1998-12-01	Sumitomo Pharmaceuticals Company, Ltd.	Naphthyridine derivatives
ATE272635T1 (en) *	1995-05-31	2004-08-15	Sumitomo Pharma	NEW NAPHTHYRIDINE DERIVATIVES.
KR20000057268A (en) *	1996-11-26	2000-09-15	다께우찌 마사야쓰	Novel naphthyridine derivatives
US6300500B1 (en)	1998-02-25	2001-10-09	Sumitomo Pharmaceuticals Company, Limited	Preparation of pyridone derivatives using phthalimido containing starting material
US6452008B2 (en)	1998-02-25	2002-09-17	Sumitomo Pharmaceuticals Company, Limited	Pyridone derivatives and process for preparing the same
CA2547518A1 (en) *	2003-12-12	2005-06-30	Wyeth	Quinolines useful in treating cardiovascular disease
CN103601677B (en) *	2013-11-19	2015-11-18	清华大学	Prepare the method for 2-alkylthio quinoline

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE892088L (en) *	1988-07-12	1990-01-12	William Henry Deryk Morris	Quinoline derivatives, their production and use
MX22406A (en) *	1989-09-15	1994-01-31	Pfizer	NEW DERIVATIVES OF N-ARIL AND N-HETEROARILAMIDAS AND UREA AS INHIBITORS OF ACIL COENZYME A: ACIL TRANSFERASA DEL COLESTEROL (ACAT).
TW205037B (en) *	1989-10-06	1993-05-01	Takeda Pharm Industry Co Ltd

1992
- 1992-03-16 WO PCT/US1992/001801 patent/WO1992019614A1/en not_active Ceased
- 1992-03-16 AU AU18797/92A patent/AU1879792A/en not_active Abandoned
- 1992-03-16 CZ CS923955A patent/CZ395592A3/en unknown
- 1992-03-16 DE DE9290049U patent/DE9290049U1/en not_active Expired - Lifetime
- 1992-03-16 JP JP4510186A patent/JPH0776215B2/en not_active Expired - Lifetime
- 1992-03-16 EP EP92923349A patent/EP0590094A1/en not_active Withdrawn
- 1992-03-16 CA CA002108014A patent/CA2108014A1/en not_active Abandoned
- 1992-03-16 HU HU9303025A patent/HUT65748A/en active IP Right Revival
- 1992-03-16 BR BR9205939A patent/BR9205939A/en not_active Application Discontinuation
- 1992-03-16 FI FI934710A patent/FI934710L/en unknown
- 1992-03-17 TW TW081102005A patent/TW197436B/zh active
- 1992-03-24 ZA ZA922976A patent/ZA922976B/en unknown
- 1992-04-16 IL IL101627A patent/IL101627A0/en unknown
- 1992-04-24 YU YU44592A patent/YU44592A/en unknown
- 1992-04-24 IE IE133092A patent/IE921330A1/en not_active Application Discontinuation
- 1992-04-24 MX MX9201916A patent/MX9201916A/en not_active IP Right Cessation
- 1992-04-24 PT PT100426A patent/PT100426A/en not_active Application Discontinuation
- 1992-04-24 NZ NZ242493A patent/NZ242493A/en unknown
- 1992-04-25 CN CN92103010A patent/CN1066068A/en active Pending
1993
- 1993-10-25 NO NO933837A patent/NO933837L/en unknown

Also Published As

Publication number	Publication date
EP0590094A1 (en)	1994-04-06
TW197436B (en)	1993-01-01
MX9201916A (en)	1992-11-01
CZ395592A3 (en)	1994-02-16
WO1992019614A1 (en)	1992-11-12
FI934710A0 (en)	1993-10-25
YU44592A (en)	1994-12-28
PT100426A (en)	1993-08-31
HU9303025D0 (en)	1994-01-28
IL101627A0 (en)	1992-12-30
BR9205939A (en)	1994-09-27
NO933837L (en)	1993-10-25
NZ242493A (en)	1994-08-26
FI934710A7 (en)	1993-10-25
ZA922976B (en)	1993-10-25
DE9290049U1 (en)	1994-01-05
HUT65748A (en)	1994-07-28
JPH0776215B2 (en)	1995-08-16
IE921330A1 (en)	1992-11-04
AU1879792A (en)	1992-12-21
CN1066068A (en)	1992-11-11
CA2108014A1 (en)	1992-10-27
JPH06501025A (en)	1994-01-27

Publication	Publication Date	Title
MX9201823A (en)	1992-10-01	QUINOLINE DERIVATIVES.
DE69208877D1 (en)	1996-04-11	CHINUCLIDINE DERIVATIVES
FI924160A7 (en)	1993-03-19	BENZANE DERIVATIVES
FI935726A7 (en)	1993-12-20	Azanorbornane derivatives
FI924159L (en)	1993-03-19	BENZANE DERIVATIVES
NO922182D0 (en)	1992-06-02	CRYSTALLINIC OXATATOLAN DERIVATIVES
DE69132519D1 (en)	2001-03-01	Quinoline derivatives
DE69119329D1 (en)	1996-06-13	Actinonine derivatives
DE69125099D1 (en)	1997-04-17	INDOLDER DERIVATIVES
FI925422L (en)	1993-05-30	Indolopyrrolocarbazole derivative
FI921262L (en)	1992-09-26	4-ARYLTHIAZOLE OR 4-ARYLIMIDAZOLE DERIVATIVES
FI925763L (en)	1993-06-21	FUNGICIDA 2-IMIDAZOLIN-5-ON- OCH 2-IMIDAZOLIN-5-THION DERIVATIVES
FI923726L (en)	1993-02-24	SULFATERADE GLYCOSAMINOGLYCANOID DERIVATIVES
FI940469A0 (en)	1994-02-01	Quinoline derivatives as immunostimulants
ATE144765T1 (en)	1996-11-15	HIV-INHIBITING BENZENACETAMIDE DERIVATIVES
FI930345L (en)	1993-01-27	FOERFARANDE FOER FRAMSTAELLNING AV RENAT ACRYLAMIDOSULPHONSYRAMONE DERIVATIVES
ATE171449T1 (en)	1998-10-15	OXADOL DERIVATIVES
NO930520D0 (en)	1993-02-12	BIFENYL-SUBSTITUTED QUINOLINE DERIVATIVES
FI913450A7 (en)	1992-01-19	Carbostyril derivatives
FI935243L (en)	1994-01-11	PYRIDONECARBOXYL DERIVATIVES
TR26336A (en)	1995-03-15	SUBSTITUTED PIRAZOLINE DERIVATIVES
DK0472733T3 (en)	1995-03-13	Phenanthrend derivatives
FI934710L (en)	1993-10-25	4-ARYL-3-(HETEROARYLUREIDO)QUINOLINE DERIVATIVES
FI920394A7 (en)	1992-08-02	3-quinuclidine derivatives
MX9206710A (en)	1993-05-01	PIRIDINOL DERIVATIVES